German Cancer Research Center

This early-phase trial tests a new vaccine called PANHPVAX in 45 healthy adults aged 18-45. The vaccine targets a part of the HPV virus (L2 antigen) to potentially protect against more HPV types than current vaccines. The main goal is to check safety and how the body responds to …

This study compares two approaches for treating advanced rare cancers: one where treatment is chosen based on a detailed genetic analysis of the tumor, and another where standard treatment is given first, with genetic testing used later if needed. About 946 adults with rare cance…

This study aims to improve treatment for metastatic breast cancer by analyzing the genetic makeup of tumors. Researchers will collect tissue and blood samples from 5,000 participants to identify specific biomarkers and drug targets. The goal is to match patients with the most pro…